Global Cell and Gene Therapy Bioassay Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Cell and Gene Therapy Bioassay Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 136

Published Date: 10 Jan 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

According to our (Global Info Research) latest study, the global Cell and Gene Therapy Bioassay Services market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Cell and Gene Therapy Bioassay Services industry chain, the market status of Pharmaceutical Company (Cell Therapy, Gene Therapy), Biotechnology (Cell Therapy, Gene Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cell and Gene Therapy Bioassay Services.

Regionally, the report analyzes the Cell and Gene Therapy Bioassay Services markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cell and Gene Therapy Bioassay Services market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Cell and Gene Therapy Bioassay Services market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cell and Gene Therapy Bioassay Services industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Cell Therapy, Gene Therapy).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cell and Gene Therapy Bioassay Services market.

Regional Analysis: The report involves examining the Cell and Gene Therapy Bioassay Services market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cell and Gene Therapy Bioassay Services market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Cell and Gene Therapy Bioassay Services:
Company Analysis: Report covers individual Cell and Gene Therapy Bioassay Services players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cell and Gene Therapy Bioassay Services This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical Company, Biotechnology).

Technology Analysis: Report covers specific technologies relevant to Cell and Gene Therapy Bioassay Services. It assesses the current state, advancements, and potential future developments in Cell and Gene Therapy Bioassay Services areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cell and Gene Therapy Bioassay Services market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Cell and Gene Therapy Bioassay Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Cell Therapy
Gene Therapy

Market segment by Application
Pharmaceutical Company
Biotechnology
Others
Mucopolysaccharidosis (MPS) Type lV A
Others

Market segment by players, this report covers
Anabiotec
Ccrm
Nexelis
Pacific Biolabs
Ppd Laboratories
Intertek Pharmaceutical Services
Lonza
Porton Biopharma Ltd
Wuxi Advanced Therapies
Avomeen
Charles River Laboratories
Absorption Systems
Bioagilytix Labs
Catalent Inc
Svar Life Science Ab

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell and Gene Therapy Bioassay Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy Bioassay Services, with revenue, gross margin and global market share of Cell and Gene Therapy Bioassay Services from 2019 to 2024.
Chapter 3, the Cell and Gene Therapy Bioassay Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cell and Gene Therapy Bioassay Services market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy Bioassay Services.
Chapter 13, to describe Cell and Gene Therapy Bioassay Services research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Cell and Gene Therapy Bioassay Services
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell and Gene Therapy Bioassay Services by Type
1.3.1 Overview: Global Cell and Gene Therapy Bioassay Services Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Type in 2023
1.3.3 Cell Therapy
1.3.4 Gene Therapy
1.4 Global Cell and Gene Therapy Bioassay Services Market by Application
1.4.1 Overview: Global Cell and Gene Therapy Bioassay Services Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharmaceutical Company
1.4.3 Biotechnology
1.4.4 Others
1.4.5 Mucopolysaccharidosis (MPS) Type lV A
1.4.6 Others
1.5 Global Cell and Gene Therapy Bioassay Services Market Size & Forecast
1.6 Global Cell and Gene Therapy Bioassay Services Market Size and Forecast by Region
1.6.1 Global Cell and Gene Therapy Bioassay Services Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Cell and Gene Therapy Bioassay Services Market Size by Region, (2019-2030)
1.6.3 North America Cell and Gene Therapy Bioassay Services Market Size and Prospect (2019-2030)
1.6.4 Europe Cell and Gene Therapy Bioassay Services Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Cell and Gene Therapy Bioassay Services Market Size and Prospect (2019-2030)
1.6.6 South America Cell and Gene Therapy Bioassay Services Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Cell and Gene Therapy Bioassay Services Market Size and Prospect (2019-2030)

2 Company Profiles
2.1 Anabiotec
2.1.1 Anabiotec Details
2.1.2 Anabiotec Major Business
2.1.3 Anabiotec Cell and Gene Therapy Bioassay Services Product and Solutions
2.1.4 Anabiotec Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Anabiotec Recent Developments and Future Plans
2.2 Ccrm
2.2.1 Ccrm Details
2.2.2 Ccrm Major Business
2.2.3 Ccrm Cell and Gene Therapy Bioassay Services Product and Solutions
2.2.4 Ccrm Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Ccrm Recent Developments and Future Plans
2.3 Nexelis
2.3.1 Nexelis Details
2.3.2 Nexelis Major Business
2.3.3 Nexelis Cell and Gene Therapy Bioassay Services Product and Solutions
2.3.4 Nexelis Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Nexelis Recent Developments and Future Plans
2.4 Pacific Biolabs
2.4.1 Pacific Biolabs Details
2.4.2 Pacific Biolabs Major Business
2.4.3 Pacific Biolabs Cell and Gene Therapy Bioassay Services Product and Solutions
2.4.4 Pacific Biolabs Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pacific Biolabs Recent Developments and Future Plans
2.5 Ppd Laboratories
2.5.1 Ppd Laboratories Details
2.5.2 Ppd Laboratories Major Business
2.5.3 Ppd Laboratories Cell and Gene Therapy Bioassay Services Product and Solutions
2.5.4 Ppd Laboratories Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Ppd Laboratories Recent Developments and Future Plans
2.6 Intertek Pharmaceutical Services
2.6.1 Intertek Pharmaceutical Services Details
2.6.2 Intertek Pharmaceutical Services Major Business
2.6.3 Intertek Pharmaceutical Services Cell and Gene Therapy Bioassay Services Product and Solutions
2.6.4 Intertek Pharmaceutical Services Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Intertek Pharmaceutical Services Recent Developments and Future Plans
2.7 Lonza
2.7.1 Lonza Details
2.7.2 Lonza Major Business
2.7.3 Lonza Cell and Gene Therapy Bioassay Services Product and Solutions
2.7.4 Lonza Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Lonza Recent Developments and Future Plans
2.8 Porton Biopharma Ltd
2.8.1 Porton Biopharma Ltd Details
2.8.2 Porton Biopharma Ltd Major Business
2.8.3 Porton Biopharma Ltd Cell and Gene Therapy Bioassay Services Product and Solutions
2.8.4 Porton Biopharma Ltd Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Porton Biopharma Ltd Recent Developments and Future Plans
2.9 Wuxi Advanced Therapies
2.9.1 Wuxi Advanced Therapies Details
2.9.2 Wuxi Advanced Therapies Major Business
2.9.3 Wuxi Advanced Therapies Cell and Gene Therapy Bioassay Services Product and Solutions
2.9.4 Wuxi Advanced Therapies Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Wuxi Advanced Therapies Recent Developments and Future Plans
2.10 Avomeen
2.10.1 Avomeen Details
2.10.2 Avomeen Major Business
2.10.3 Avomeen Cell and Gene Therapy Bioassay Services Product and Solutions
2.10.4 Avomeen Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Avomeen Recent Developments and Future Plans
2.11 Charles River Laboratories
2.11.1 Charles River Laboratories Details
2.11.2 Charles River Laboratories Major Business
2.11.3 Charles River Laboratories Cell and Gene Therapy Bioassay Services Product and Solutions
2.11.4 Charles River Laboratories Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Charles River Laboratories Recent Developments and Future Plans
2.12 Absorption Systems
2.12.1 Absorption Systems Details
2.12.2 Absorption Systems Major Business
2.12.3 Absorption Systems Cell and Gene Therapy Bioassay Services Product and Solutions
2.12.4 Absorption Systems Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Absorption Systems Recent Developments and Future Plans
2.13 Bioagilytix Labs
2.13.1 Bioagilytix Labs Details
2.13.2 Bioagilytix Labs Major Business
2.13.3 Bioagilytix Labs Cell and Gene Therapy Bioassay Services Product and Solutions
2.13.4 Bioagilytix Labs Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Bioagilytix Labs Recent Developments and Future Plans
2.14 Catalent Inc
2.14.1 Catalent Inc Details
2.14.2 Catalent Inc Major Business
2.14.3 Catalent Inc Cell and Gene Therapy Bioassay Services Product and Solutions
2.14.4 Catalent Inc Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Catalent Inc Recent Developments and Future Plans
2.15 Svar Life Science Ab
2.15.1 Svar Life Science Ab Details
2.15.2 Svar Life Science Ab Major Business
2.15.3 Svar Life Science Ab Cell and Gene Therapy Bioassay Services Product and Solutions
2.15.4 Svar Life Science Ab Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Svar Life Science Ab Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Cell and Gene Therapy Bioassay Services Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Cell and Gene Therapy Bioassay Services by Company Revenue
3.2.2 Top 3 Cell and Gene Therapy Bioassay Services Players Market Share in 2023
3.2.3 Top 6 Cell and Gene Therapy Bioassay Services Players Market Share in 2023
3.3 Cell and Gene Therapy Bioassay Services Market: Overall Company Footprint Analysis
3.3.1 Cell and Gene Therapy Bioassay Services Market: Region Footprint
3.3.2 Cell and Gene Therapy Bioassay Services Market: Company Product Type Footprint
3.3.3 Cell and Gene Therapy Bioassay Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Cell and Gene Therapy Bioassay Services Consumption Value and Market Share by Type (2019-2024)
4.2 Global Cell and Gene Therapy Bioassay Services Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
5.1 Global Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Application (2019-2024)
5.2 Global Cell and Gene Therapy Bioassay Services Market Forecast by Application (2025-2030)

6 North America
6.1 North America Cell and Gene Therapy Bioassay Services Consumption Value by Type (2019-2030)
6.2 North America Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2030)
6.3 North America Cell and Gene Therapy Bioassay Services Market Size by Country
6.3.1 North America Cell and Gene Therapy Bioassay Services Consumption Value by Country (2019-2030)
6.3.2 United States Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
6.3.3 Canada Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
6.3.4 Mexico Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)

7 Europe
7.1 Europe Cell and Gene Therapy Bioassay Services Consumption Value by Type (2019-2030)
7.2 Europe Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2030)
7.3 Europe Cell and Gene Therapy Bioassay Services Market Size by Country
7.3.1 Europe Cell and Gene Therapy Bioassay Services Consumption Value by Country (2019-2030)
7.3.2 Germany Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
7.3.3 France Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
7.3.5 Russia Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
7.3.6 Italy Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)

8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Cell and Gene Therapy Bioassay Services Market Size by Region
8.3.1 Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value by Region (2019-2030)
8.3.2 China Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
8.3.3 Japan Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
8.3.4 South Korea Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
8.3.5 India Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
8.3.7 Australia Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)

9 South America
9.1 South America Cell and Gene Therapy Bioassay Services Consumption Value by Type (2019-2030)
9.2 South America Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2030)
9.3 South America Cell and Gene Therapy Bioassay Services Market Size by Country
9.3.1 South America Cell and Gene Therapy Bioassay Services Consumption Value by Country (2019-2030)
9.3.2 Brazil Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
9.3.3 Argentina Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)

10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Bioassay Services Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Cell and Gene Therapy Bioassay Services Market Size by Country
10.3.1 Middle East & Africa Cell and Gene Therapy Bioassay Services Consumption Value by Country (2019-2030)
10.3.2 Turkey Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
10.3.4 UAE Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)

11 Market Dynamics
11.1 Cell and Gene Therapy Bioassay Services Market Drivers
11.2 Cell and Gene Therapy Bioassay Services Market Restraints
11.3 Cell and Gene Therapy Bioassay Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry

12 Industry Chain Analysis
12.1 Cell and Gene Therapy Bioassay Services Industry Chain
12.2 Cell and Gene Therapy Bioassay Services Upstream Analysis
12.3 Cell and Gene Therapy Bioassay Services Midstream Analysis
12.4 Cell and Gene Therapy Bioassay Services Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Cell and Gene Therapy Bioassay Services Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Cell and Gene Therapy Bioassay Services Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Cell and Gene Therapy Bioassay Services Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Cell and Gene Therapy Bioassay Services Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Anabiotec Company Information, Head Office, and Major Competitors
Table 6. Anabiotec Major Business
Table 7. Anabiotec Cell and Gene Therapy Bioassay Services Product and Solutions
Table 8. Anabiotec Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Anabiotec Recent Developments and Future Plans
Table 10. Ccrm Company Information, Head Office, and Major Competitors
Table 11. Ccrm Major Business
Table 12. Ccrm Cell and Gene Therapy Bioassay Services Product and Solutions
Table 13. Ccrm Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Ccrm Recent Developments and Future Plans
Table 15. Nexelis Company Information, Head Office, and Major Competitors
Table 16. Nexelis Major Business
Table 17. Nexelis Cell and Gene Therapy Bioassay Services Product and Solutions
Table 18. Nexelis Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Nexelis Recent Developments and Future Plans
Table 20. Pacific Biolabs Company Information, Head Office, and Major Competitors
Table 21. Pacific Biolabs Major Business
Table 22. Pacific Biolabs Cell and Gene Therapy Bioassay Services Product and Solutions
Table 23. Pacific Biolabs Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Pacific Biolabs Recent Developments and Future Plans
Table 25. Ppd Laboratories Company Information, Head Office, and Major Competitors
Table 26. Ppd Laboratories Major Business
Table 27. Ppd Laboratories Cell and Gene Therapy Bioassay Services Product and Solutions
Table 28. Ppd Laboratories Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Ppd Laboratories Recent Developments and Future Plans
Table 30. Intertek Pharmaceutical Services Company Information, Head Office, and Major Competitors
Table 31. Intertek Pharmaceutical Services Major Business
Table 32. Intertek Pharmaceutical Services Cell and Gene Therapy Bioassay Services Product and Solutions
Table 33. Intertek Pharmaceutical Services Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Intertek Pharmaceutical Services Recent Developments and Future Plans
Table 35. Lonza Company Information, Head Office, and Major Competitors
Table 36. Lonza Major Business
Table 37. Lonza Cell and Gene Therapy Bioassay Services Product and Solutions
Table 38. Lonza Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Lonza Recent Developments and Future Plans
Table 40. Porton Biopharma Ltd Company Information, Head Office, and Major Competitors
Table 41. Porton Biopharma Ltd Major Business
Table 42. Porton Biopharma Ltd Cell and Gene Therapy Bioassay Services Product and Solutions
Table 43. Porton Biopharma Ltd Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Porton Biopharma Ltd Recent Developments and Future Plans
Table 45. Wuxi Advanced Therapies Company Information, Head Office, and Major Competitors
Table 46. Wuxi Advanced Therapies Major Business
Table 47. Wuxi Advanced Therapies Cell and Gene Therapy Bioassay Services Product and Solutions
Table 48. Wuxi Advanced Therapies Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Wuxi Advanced Therapies Recent Developments and Future Plans
Table 50. Avomeen Company Information, Head Office, and Major Competitors
Table 51. Avomeen Major Business
Table 52. Avomeen Cell and Gene Therapy Bioassay Services Product and Solutions
Table 53. Avomeen Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Avomeen Recent Developments and Future Plans
Table 55. Charles River Laboratories Company Information, Head Office, and Major Competitors
Table 56. Charles River Laboratories Major Business
Table 57. Charles River Laboratories Cell and Gene Therapy Bioassay Services Product and Solutions
Table 58. Charles River Laboratories Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Charles River Laboratories Recent Developments and Future Plans
Table 60. Absorption Systems Company Information, Head Office, and Major Competitors
Table 61. Absorption Systems Major Business
Table 62. Absorption Systems Cell and Gene Therapy Bioassay Services Product and Solutions
Table 63. Absorption Systems Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Absorption Systems Recent Developments and Future Plans
Table 65. Bioagilytix Labs Company Information, Head Office, and Major Competitors
Table 66. Bioagilytix Labs Major Business
Table 67. Bioagilytix Labs Cell and Gene Therapy Bioassay Services Product and Solutions
Table 68. Bioagilytix Labs Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Bioagilytix Labs Recent Developments and Future Plans
Table 70. Catalent Inc Company Information, Head Office, and Major Competitors
Table 71. Catalent Inc Major Business
Table 72. Catalent Inc Cell and Gene Therapy Bioassay Services Product and Solutions
Table 73. Catalent Inc Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Catalent Inc Recent Developments and Future Plans
Table 75. Svar Life Science Ab Company Information, Head Office, and Major Competitors
Table 76. Svar Life Science Ab Major Business
Table 77. Svar Life Science Ab Cell and Gene Therapy Bioassay Services Product and Solutions
Table 78. Svar Life Science Ab Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Svar Life Science Ab Recent Developments and Future Plans
Table 80. Global Cell and Gene Therapy Bioassay Services Revenue (USD Million) by Players (2019-2024)
Table 81. Global Cell and Gene Therapy Bioassay Services Revenue Share by Players (2019-2024)
Table 82. Breakdown of Cell and Gene Therapy Bioassay Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Cell and Gene Therapy Bioassay Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 84. Head Office of Key Cell and Gene Therapy Bioassay Services Players
Table 85. Cell and Gene Therapy Bioassay Services Market: Company Product Type Footprint
Table 86. Cell and Gene Therapy Bioassay Services Market: Company Product Application Footprint
Table 87. Cell and Gene Therapy Bioassay Services New Market Entrants and Barriers to Market Entry
Table 88. Cell and Gene Therapy Bioassay Services Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Cell and Gene Therapy Bioassay Services Consumption Value (USD Million) by Type (2019-2024)
Table 90. Global Cell and Gene Therapy Bioassay Services Consumption Value Share by Type (2019-2024)
Table 91. Global Cell and Gene Therapy Bioassay Services Consumption Value Forecast by Type (2025-2030)
Table 92. Global Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2024)
Table 93. Global Cell and Gene Therapy Bioassay Services Consumption Value Forecast by Application (2025-2030)
Table 94. North America Cell and Gene Therapy Bioassay Services Consumption Value by Type (2019-2024) & (USD Million)
Table 95. North America Cell and Gene Therapy Bioassay Services Consumption Value by Type (2025-2030) & (USD Million)
Table 96. North America Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2024) & (USD Million)
Table 97. North America Cell and Gene Therapy Bioassay Services Consumption Value by Application (2025-2030) & (USD Million)
Table 98. North America Cell and Gene Therapy Bioassay Services Consumption Value by Country (2019-2024) & (USD Million)
Table 99. North America Cell and Gene Therapy Bioassay Services Consumption Value by Country (2025-2030) & (USD Million)
Table 100. Europe Cell and Gene Therapy Bioassay Services Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Europe Cell and Gene Therapy Bioassay Services Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Europe Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2024) & (USD Million)
Table 103. Europe Cell and Gene Therapy Bioassay Services Consumption Value by Application (2025-2030) & (USD Million)
Table 104. Europe Cell and Gene Therapy Bioassay Services Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Cell and Gene Therapy Bioassay Services Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value by Type (2019-2024) & (USD Million)
Table 107. Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value by Type (2025-2030) & (USD Million)
Table 108. Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2024) & (USD Million)
Table 109. Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value by Application (2025-2030) & (USD Million)
Table 110. Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value by Region (2019-2024) & (USD Million)
Table 111. Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value by Region (2025-2030) & (USD Million)
Table 112. South America Cell and Gene Therapy Bioassay Services Consumption Value by Type (2019-2024) & (USD Million)
Table 113. South America Cell and Gene Therapy Bioassay Services Consumption Value by Type (2025-2030) & (USD Million)
Table 114. South America Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2024) & (USD Million)
Table 115. South America Cell and Gene Therapy Bioassay Services Consumption Value by Application (2025-2030) & (USD Million)
Table 116. South America Cell and Gene Therapy Bioassay Services Consumption Value by Country (2019-2024) & (USD Million)
Table 117. South America Cell and Gene Therapy Bioassay Services Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Middle East & Africa Cell and Gene Therapy Bioassay Services Consumption Value by Type (2019-2024) & (USD Million)
Table 119. Middle East & Africa Cell and Gene Therapy Bioassay Services Consumption Value by Type (2025-2030) & (USD Million)
Table 120. Middle East & Africa Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2024) & (USD Million)
Table 121. Middle East & Africa Cell and Gene Therapy Bioassay Services Consumption Value by Application (2025-2030) & (USD Million)
Table 122. Middle East & Africa Cell and Gene Therapy Bioassay Services Consumption Value by Country (2019-2024) & (USD Million)
Table 123. Middle East & Africa Cell and Gene Therapy Bioassay Services Consumption Value by Country (2025-2030) & (USD Million)
Table 124. Cell and Gene Therapy Bioassay Services Raw Material
Table 125. Key Suppliers of Cell and Gene Therapy Bioassay Services Raw Materials
List of Figures
Figure 1. Cell and Gene Therapy Bioassay Services Picture
Figure 2. Global Cell and Gene Therapy Bioassay Services Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Type in 2023
Figure 4. Cell Therapy
Figure 5. Gene Therapy
Figure 6. Global Cell and Gene Therapy Bioassay Services Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Application in 2023
Figure 8. Pharmaceutical Company Picture
Figure 9. Biotechnology Picture
Figure 10. Others Picture
Figure 11. Mucopolysaccharidosis (MPS) Type lV A Picture
Figure 12. Others Picture
Figure 13. Global Cell and Gene Therapy Bioassay Services Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Cell and Gene Therapy Bioassay Services Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Cell and Gene Therapy Bioassay Services Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Region in 2023
Figure 18. North America Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Cell and Gene Therapy Bioassay Services Revenue Share by Players in 2023
Figure 24. Cell and Gene Therapy Bioassay Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Cell and Gene Therapy Bioassay Services Market Share in 2023
Figure 26. Global Top 6 Players Cell and Gene Therapy Bioassay Services Market Share in 2023
Figure 27. Global Cell and Gene Therapy Bioassay Services Consumption Value Share by Type (2019-2024)
Figure 28. Global Cell and Gene Therapy Bioassay Services Market Share Forecast by Type (2025-2030)
Figure 29. Global Cell and Gene Therapy Bioassay Services Consumption Value Share by Application (2019-2024)
Figure 30. Global Cell and Gene Therapy Bioassay Services Market Share Forecast by Application (2025-2030)
Figure 31. North America Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 41. France Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Region (2019-2030)
Figure 48. China Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 51. India Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 65. Cell and Gene Therapy Bioassay Services Market Drivers
Figure 66. Cell and Gene Therapy Bioassay Services Market Restraints
Figure 67. Cell and Gene Therapy Bioassay Services Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Cell and Gene Therapy Bioassay Services in 2023
Figure 70. Manufacturing Process Analysis of Cell and Gene Therapy Bioassay Services
Figure 71. Cell and Gene Therapy Bioassay Services Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Anabiotec
Ccrm
Nexelis
Pacific Biolabs
Ppd Laboratories
Intertek Pharmaceutical Services
Lonza
Porton Biopharma Ltd
Wuxi Advanced Therapies
Avomeen
Charles River Laboratories
Absorption Systems
Bioagilytix Labs
Catalent Inc
Svar Life Science Ab
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Cell and Gene Therapy Bioassay Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Cell and Gene Therapy Bioassay Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 136

Published Date: 10 Jan 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

According to our (Global Info Research) latest study, the global Cell and Gene Therapy Bioassay Services market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Cell and Gene Therapy Bioassay Services industry chain, the market status of Pharmaceutical Company (Cell Therapy, Gene Therapy), Biotechnology (Cell Therapy, Gene Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cell and Gene Therapy Bioassay Services.

Regionally, the report analyzes the Cell and Gene Therapy Bioassay Services markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cell and Gene Therapy Bioassay Services market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Cell and Gene Therapy Bioassay Services market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cell and Gene Therapy Bioassay Services industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Cell Therapy, Gene Therapy).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cell and Gene Therapy Bioassay Services market.

Regional Analysis: The report involves examining the Cell and Gene Therapy Bioassay Services market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cell and Gene Therapy Bioassay Services market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Cell and Gene Therapy Bioassay Services:
Company Analysis: Report covers individual Cell and Gene Therapy Bioassay Services players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cell and Gene Therapy Bioassay Services This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical Company, Biotechnology).

Technology Analysis: Report covers specific technologies relevant to Cell and Gene Therapy Bioassay Services. It assesses the current state, advancements, and potential future developments in Cell and Gene Therapy Bioassay Services areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cell and Gene Therapy Bioassay Services market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Cell and Gene Therapy Bioassay Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Cell Therapy
Gene Therapy

Market segment by Application
Pharmaceutical Company
Biotechnology
Others
Mucopolysaccharidosis (MPS) Type lV A
Others

Market segment by players, this report covers
Anabiotec
Ccrm
Nexelis
Pacific Biolabs
Ppd Laboratories
Intertek Pharmaceutical Services
Lonza
Porton Biopharma Ltd
Wuxi Advanced Therapies
Avomeen
Charles River Laboratories
Absorption Systems
Bioagilytix Labs
Catalent Inc
Svar Life Science Ab

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell and Gene Therapy Bioassay Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy Bioassay Services, with revenue, gross margin and global market share of Cell and Gene Therapy Bioassay Services from 2019 to 2024.
Chapter 3, the Cell and Gene Therapy Bioassay Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cell and Gene Therapy Bioassay Services market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy Bioassay Services.
Chapter 13, to describe Cell and Gene Therapy Bioassay Services research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Cell and Gene Therapy Bioassay Services
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell and Gene Therapy Bioassay Services by Type
1.3.1 Overview: Global Cell and Gene Therapy Bioassay Services Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Type in 2023
1.3.3 Cell Therapy
1.3.4 Gene Therapy
1.4 Global Cell and Gene Therapy Bioassay Services Market by Application
1.4.1 Overview: Global Cell and Gene Therapy Bioassay Services Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharmaceutical Company
1.4.3 Biotechnology
1.4.4 Others
1.4.5 Mucopolysaccharidosis (MPS) Type lV A
1.4.6 Others
1.5 Global Cell and Gene Therapy Bioassay Services Market Size & Forecast
1.6 Global Cell and Gene Therapy Bioassay Services Market Size and Forecast by Region
1.6.1 Global Cell and Gene Therapy Bioassay Services Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Cell and Gene Therapy Bioassay Services Market Size by Region, (2019-2030)
1.6.3 North America Cell and Gene Therapy Bioassay Services Market Size and Prospect (2019-2030)
1.6.4 Europe Cell and Gene Therapy Bioassay Services Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Cell and Gene Therapy Bioassay Services Market Size and Prospect (2019-2030)
1.6.6 South America Cell and Gene Therapy Bioassay Services Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Cell and Gene Therapy Bioassay Services Market Size and Prospect (2019-2030)

2 Company Profiles
2.1 Anabiotec
2.1.1 Anabiotec Details
2.1.2 Anabiotec Major Business
2.1.3 Anabiotec Cell and Gene Therapy Bioassay Services Product and Solutions
2.1.4 Anabiotec Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Anabiotec Recent Developments and Future Plans
2.2 Ccrm
2.2.1 Ccrm Details
2.2.2 Ccrm Major Business
2.2.3 Ccrm Cell and Gene Therapy Bioassay Services Product and Solutions
2.2.4 Ccrm Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Ccrm Recent Developments and Future Plans
2.3 Nexelis
2.3.1 Nexelis Details
2.3.2 Nexelis Major Business
2.3.3 Nexelis Cell and Gene Therapy Bioassay Services Product and Solutions
2.3.4 Nexelis Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Nexelis Recent Developments and Future Plans
2.4 Pacific Biolabs
2.4.1 Pacific Biolabs Details
2.4.2 Pacific Biolabs Major Business
2.4.3 Pacific Biolabs Cell and Gene Therapy Bioassay Services Product and Solutions
2.4.4 Pacific Biolabs Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pacific Biolabs Recent Developments and Future Plans
2.5 Ppd Laboratories
2.5.1 Ppd Laboratories Details
2.5.2 Ppd Laboratories Major Business
2.5.3 Ppd Laboratories Cell and Gene Therapy Bioassay Services Product and Solutions
2.5.4 Ppd Laboratories Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Ppd Laboratories Recent Developments and Future Plans
2.6 Intertek Pharmaceutical Services
2.6.1 Intertek Pharmaceutical Services Details
2.6.2 Intertek Pharmaceutical Services Major Business
2.6.3 Intertek Pharmaceutical Services Cell and Gene Therapy Bioassay Services Product and Solutions
2.6.4 Intertek Pharmaceutical Services Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Intertek Pharmaceutical Services Recent Developments and Future Plans
2.7 Lonza
2.7.1 Lonza Details
2.7.2 Lonza Major Business
2.7.3 Lonza Cell and Gene Therapy Bioassay Services Product and Solutions
2.7.4 Lonza Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Lonza Recent Developments and Future Plans
2.8 Porton Biopharma Ltd
2.8.1 Porton Biopharma Ltd Details
2.8.2 Porton Biopharma Ltd Major Business
2.8.3 Porton Biopharma Ltd Cell and Gene Therapy Bioassay Services Product and Solutions
2.8.4 Porton Biopharma Ltd Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Porton Biopharma Ltd Recent Developments and Future Plans
2.9 Wuxi Advanced Therapies
2.9.1 Wuxi Advanced Therapies Details
2.9.2 Wuxi Advanced Therapies Major Business
2.9.3 Wuxi Advanced Therapies Cell and Gene Therapy Bioassay Services Product and Solutions
2.9.4 Wuxi Advanced Therapies Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Wuxi Advanced Therapies Recent Developments and Future Plans
2.10 Avomeen
2.10.1 Avomeen Details
2.10.2 Avomeen Major Business
2.10.3 Avomeen Cell and Gene Therapy Bioassay Services Product and Solutions
2.10.4 Avomeen Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Avomeen Recent Developments and Future Plans
2.11 Charles River Laboratories
2.11.1 Charles River Laboratories Details
2.11.2 Charles River Laboratories Major Business
2.11.3 Charles River Laboratories Cell and Gene Therapy Bioassay Services Product and Solutions
2.11.4 Charles River Laboratories Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Charles River Laboratories Recent Developments and Future Plans
2.12 Absorption Systems
2.12.1 Absorption Systems Details
2.12.2 Absorption Systems Major Business
2.12.3 Absorption Systems Cell and Gene Therapy Bioassay Services Product and Solutions
2.12.4 Absorption Systems Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Absorption Systems Recent Developments and Future Plans
2.13 Bioagilytix Labs
2.13.1 Bioagilytix Labs Details
2.13.2 Bioagilytix Labs Major Business
2.13.3 Bioagilytix Labs Cell and Gene Therapy Bioassay Services Product and Solutions
2.13.4 Bioagilytix Labs Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Bioagilytix Labs Recent Developments and Future Plans
2.14 Catalent Inc
2.14.1 Catalent Inc Details
2.14.2 Catalent Inc Major Business
2.14.3 Catalent Inc Cell and Gene Therapy Bioassay Services Product and Solutions
2.14.4 Catalent Inc Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Catalent Inc Recent Developments and Future Plans
2.15 Svar Life Science Ab
2.15.1 Svar Life Science Ab Details
2.15.2 Svar Life Science Ab Major Business
2.15.3 Svar Life Science Ab Cell and Gene Therapy Bioassay Services Product and Solutions
2.15.4 Svar Life Science Ab Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Svar Life Science Ab Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Cell and Gene Therapy Bioassay Services Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Cell and Gene Therapy Bioassay Services by Company Revenue
3.2.2 Top 3 Cell and Gene Therapy Bioassay Services Players Market Share in 2023
3.2.3 Top 6 Cell and Gene Therapy Bioassay Services Players Market Share in 2023
3.3 Cell and Gene Therapy Bioassay Services Market: Overall Company Footprint Analysis
3.3.1 Cell and Gene Therapy Bioassay Services Market: Region Footprint
3.3.2 Cell and Gene Therapy Bioassay Services Market: Company Product Type Footprint
3.3.3 Cell and Gene Therapy Bioassay Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Cell and Gene Therapy Bioassay Services Consumption Value and Market Share by Type (2019-2024)
4.2 Global Cell and Gene Therapy Bioassay Services Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
5.1 Global Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Application (2019-2024)
5.2 Global Cell and Gene Therapy Bioassay Services Market Forecast by Application (2025-2030)

6 North America
6.1 North America Cell and Gene Therapy Bioassay Services Consumption Value by Type (2019-2030)
6.2 North America Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2030)
6.3 North America Cell and Gene Therapy Bioassay Services Market Size by Country
6.3.1 North America Cell and Gene Therapy Bioassay Services Consumption Value by Country (2019-2030)
6.3.2 United States Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
6.3.3 Canada Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
6.3.4 Mexico Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)

7 Europe
7.1 Europe Cell and Gene Therapy Bioassay Services Consumption Value by Type (2019-2030)
7.2 Europe Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2030)
7.3 Europe Cell and Gene Therapy Bioassay Services Market Size by Country
7.3.1 Europe Cell and Gene Therapy Bioassay Services Consumption Value by Country (2019-2030)
7.3.2 Germany Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
7.3.3 France Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
7.3.5 Russia Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
7.3.6 Italy Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)

8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Cell and Gene Therapy Bioassay Services Market Size by Region
8.3.1 Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value by Region (2019-2030)
8.3.2 China Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
8.3.3 Japan Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
8.3.4 South Korea Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
8.3.5 India Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
8.3.7 Australia Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)

9 South America
9.1 South America Cell and Gene Therapy Bioassay Services Consumption Value by Type (2019-2030)
9.2 South America Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2030)
9.3 South America Cell and Gene Therapy Bioassay Services Market Size by Country
9.3.1 South America Cell and Gene Therapy Bioassay Services Consumption Value by Country (2019-2030)
9.3.2 Brazil Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
9.3.3 Argentina Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)

10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Bioassay Services Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Cell and Gene Therapy Bioassay Services Market Size by Country
10.3.1 Middle East & Africa Cell and Gene Therapy Bioassay Services Consumption Value by Country (2019-2030)
10.3.2 Turkey Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)
10.3.4 UAE Cell and Gene Therapy Bioassay Services Market Size and Forecast (2019-2030)

11 Market Dynamics
11.1 Cell and Gene Therapy Bioassay Services Market Drivers
11.2 Cell and Gene Therapy Bioassay Services Market Restraints
11.3 Cell and Gene Therapy Bioassay Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry

12 Industry Chain Analysis
12.1 Cell and Gene Therapy Bioassay Services Industry Chain
12.2 Cell and Gene Therapy Bioassay Services Upstream Analysis
12.3 Cell and Gene Therapy Bioassay Services Midstream Analysis
12.4 Cell and Gene Therapy Bioassay Services Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Cell and Gene Therapy Bioassay Services Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Cell and Gene Therapy Bioassay Services Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Cell and Gene Therapy Bioassay Services Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Cell and Gene Therapy Bioassay Services Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Anabiotec Company Information, Head Office, and Major Competitors
Table 6. Anabiotec Major Business
Table 7. Anabiotec Cell and Gene Therapy Bioassay Services Product and Solutions
Table 8. Anabiotec Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Anabiotec Recent Developments and Future Plans
Table 10. Ccrm Company Information, Head Office, and Major Competitors
Table 11. Ccrm Major Business
Table 12. Ccrm Cell and Gene Therapy Bioassay Services Product and Solutions
Table 13. Ccrm Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Ccrm Recent Developments and Future Plans
Table 15. Nexelis Company Information, Head Office, and Major Competitors
Table 16. Nexelis Major Business
Table 17. Nexelis Cell and Gene Therapy Bioassay Services Product and Solutions
Table 18. Nexelis Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Nexelis Recent Developments and Future Plans
Table 20. Pacific Biolabs Company Information, Head Office, and Major Competitors
Table 21. Pacific Biolabs Major Business
Table 22. Pacific Biolabs Cell and Gene Therapy Bioassay Services Product and Solutions
Table 23. Pacific Biolabs Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Pacific Biolabs Recent Developments and Future Plans
Table 25. Ppd Laboratories Company Information, Head Office, and Major Competitors
Table 26. Ppd Laboratories Major Business
Table 27. Ppd Laboratories Cell and Gene Therapy Bioassay Services Product and Solutions
Table 28. Ppd Laboratories Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Ppd Laboratories Recent Developments and Future Plans
Table 30. Intertek Pharmaceutical Services Company Information, Head Office, and Major Competitors
Table 31. Intertek Pharmaceutical Services Major Business
Table 32. Intertek Pharmaceutical Services Cell and Gene Therapy Bioassay Services Product and Solutions
Table 33. Intertek Pharmaceutical Services Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Intertek Pharmaceutical Services Recent Developments and Future Plans
Table 35. Lonza Company Information, Head Office, and Major Competitors
Table 36. Lonza Major Business
Table 37. Lonza Cell and Gene Therapy Bioassay Services Product and Solutions
Table 38. Lonza Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Lonza Recent Developments and Future Plans
Table 40. Porton Biopharma Ltd Company Information, Head Office, and Major Competitors
Table 41. Porton Biopharma Ltd Major Business
Table 42. Porton Biopharma Ltd Cell and Gene Therapy Bioassay Services Product and Solutions
Table 43. Porton Biopharma Ltd Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Porton Biopharma Ltd Recent Developments and Future Plans
Table 45. Wuxi Advanced Therapies Company Information, Head Office, and Major Competitors
Table 46. Wuxi Advanced Therapies Major Business
Table 47. Wuxi Advanced Therapies Cell and Gene Therapy Bioassay Services Product and Solutions
Table 48. Wuxi Advanced Therapies Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Wuxi Advanced Therapies Recent Developments and Future Plans
Table 50. Avomeen Company Information, Head Office, and Major Competitors
Table 51. Avomeen Major Business
Table 52. Avomeen Cell and Gene Therapy Bioassay Services Product and Solutions
Table 53. Avomeen Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Avomeen Recent Developments and Future Plans
Table 55. Charles River Laboratories Company Information, Head Office, and Major Competitors
Table 56. Charles River Laboratories Major Business
Table 57. Charles River Laboratories Cell and Gene Therapy Bioassay Services Product and Solutions
Table 58. Charles River Laboratories Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Charles River Laboratories Recent Developments and Future Plans
Table 60. Absorption Systems Company Information, Head Office, and Major Competitors
Table 61. Absorption Systems Major Business
Table 62. Absorption Systems Cell and Gene Therapy Bioassay Services Product and Solutions
Table 63. Absorption Systems Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Absorption Systems Recent Developments and Future Plans
Table 65. Bioagilytix Labs Company Information, Head Office, and Major Competitors
Table 66. Bioagilytix Labs Major Business
Table 67. Bioagilytix Labs Cell and Gene Therapy Bioassay Services Product and Solutions
Table 68. Bioagilytix Labs Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Bioagilytix Labs Recent Developments and Future Plans
Table 70. Catalent Inc Company Information, Head Office, and Major Competitors
Table 71. Catalent Inc Major Business
Table 72. Catalent Inc Cell and Gene Therapy Bioassay Services Product and Solutions
Table 73. Catalent Inc Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Catalent Inc Recent Developments and Future Plans
Table 75. Svar Life Science Ab Company Information, Head Office, and Major Competitors
Table 76. Svar Life Science Ab Major Business
Table 77. Svar Life Science Ab Cell and Gene Therapy Bioassay Services Product and Solutions
Table 78. Svar Life Science Ab Cell and Gene Therapy Bioassay Services Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Svar Life Science Ab Recent Developments and Future Plans
Table 80. Global Cell and Gene Therapy Bioassay Services Revenue (USD Million) by Players (2019-2024)
Table 81. Global Cell and Gene Therapy Bioassay Services Revenue Share by Players (2019-2024)
Table 82. Breakdown of Cell and Gene Therapy Bioassay Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Cell and Gene Therapy Bioassay Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 84. Head Office of Key Cell and Gene Therapy Bioassay Services Players
Table 85. Cell and Gene Therapy Bioassay Services Market: Company Product Type Footprint
Table 86. Cell and Gene Therapy Bioassay Services Market: Company Product Application Footprint
Table 87. Cell and Gene Therapy Bioassay Services New Market Entrants and Barriers to Market Entry
Table 88. Cell and Gene Therapy Bioassay Services Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Cell and Gene Therapy Bioassay Services Consumption Value (USD Million) by Type (2019-2024)
Table 90. Global Cell and Gene Therapy Bioassay Services Consumption Value Share by Type (2019-2024)
Table 91. Global Cell and Gene Therapy Bioassay Services Consumption Value Forecast by Type (2025-2030)
Table 92. Global Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2024)
Table 93. Global Cell and Gene Therapy Bioassay Services Consumption Value Forecast by Application (2025-2030)
Table 94. North America Cell and Gene Therapy Bioassay Services Consumption Value by Type (2019-2024) & (USD Million)
Table 95. North America Cell and Gene Therapy Bioassay Services Consumption Value by Type (2025-2030) & (USD Million)
Table 96. North America Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2024) & (USD Million)
Table 97. North America Cell and Gene Therapy Bioassay Services Consumption Value by Application (2025-2030) & (USD Million)
Table 98. North America Cell and Gene Therapy Bioassay Services Consumption Value by Country (2019-2024) & (USD Million)
Table 99. North America Cell and Gene Therapy Bioassay Services Consumption Value by Country (2025-2030) & (USD Million)
Table 100. Europe Cell and Gene Therapy Bioassay Services Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Europe Cell and Gene Therapy Bioassay Services Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Europe Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2024) & (USD Million)
Table 103. Europe Cell and Gene Therapy Bioassay Services Consumption Value by Application (2025-2030) & (USD Million)
Table 104. Europe Cell and Gene Therapy Bioassay Services Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Cell and Gene Therapy Bioassay Services Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value by Type (2019-2024) & (USD Million)
Table 107. Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value by Type (2025-2030) & (USD Million)
Table 108. Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2024) & (USD Million)
Table 109. Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value by Application (2025-2030) & (USD Million)
Table 110. Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value by Region (2019-2024) & (USD Million)
Table 111. Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value by Region (2025-2030) & (USD Million)
Table 112. South America Cell and Gene Therapy Bioassay Services Consumption Value by Type (2019-2024) & (USD Million)
Table 113. South America Cell and Gene Therapy Bioassay Services Consumption Value by Type (2025-2030) & (USD Million)
Table 114. South America Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2024) & (USD Million)
Table 115. South America Cell and Gene Therapy Bioassay Services Consumption Value by Application (2025-2030) & (USD Million)
Table 116. South America Cell and Gene Therapy Bioassay Services Consumption Value by Country (2019-2024) & (USD Million)
Table 117. South America Cell and Gene Therapy Bioassay Services Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Middle East & Africa Cell and Gene Therapy Bioassay Services Consumption Value by Type (2019-2024) & (USD Million)
Table 119. Middle East & Africa Cell and Gene Therapy Bioassay Services Consumption Value by Type (2025-2030) & (USD Million)
Table 120. Middle East & Africa Cell and Gene Therapy Bioassay Services Consumption Value by Application (2019-2024) & (USD Million)
Table 121. Middle East & Africa Cell and Gene Therapy Bioassay Services Consumption Value by Application (2025-2030) & (USD Million)
Table 122. Middle East & Africa Cell and Gene Therapy Bioassay Services Consumption Value by Country (2019-2024) & (USD Million)
Table 123. Middle East & Africa Cell and Gene Therapy Bioassay Services Consumption Value by Country (2025-2030) & (USD Million)
Table 124. Cell and Gene Therapy Bioassay Services Raw Material
Table 125. Key Suppliers of Cell and Gene Therapy Bioassay Services Raw Materials
List of Figures
Figure 1. Cell and Gene Therapy Bioassay Services Picture
Figure 2. Global Cell and Gene Therapy Bioassay Services Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Type in 2023
Figure 4. Cell Therapy
Figure 5. Gene Therapy
Figure 6. Global Cell and Gene Therapy Bioassay Services Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Application in 2023
Figure 8. Pharmaceutical Company Picture
Figure 9. Biotechnology Picture
Figure 10. Others Picture
Figure 11. Mucopolysaccharidosis (MPS) Type lV A Picture
Figure 12. Others Picture
Figure 13. Global Cell and Gene Therapy Bioassay Services Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Cell and Gene Therapy Bioassay Services Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Cell and Gene Therapy Bioassay Services Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Region in 2023
Figure 18. North America Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Cell and Gene Therapy Bioassay Services Revenue Share by Players in 2023
Figure 24. Cell and Gene Therapy Bioassay Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Cell and Gene Therapy Bioassay Services Market Share in 2023
Figure 26. Global Top 6 Players Cell and Gene Therapy Bioassay Services Market Share in 2023
Figure 27. Global Cell and Gene Therapy Bioassay Services Consumption Value Share by Type (2019-2024)
Figure 28. Global Cell and Gene Therapy Bioassay Services Market Share Forecast by Type (2025-2030)
Figure 29. Global Cell and Gene Therapy Bioassay Services Consumption Value Share by Application (2019-2024)
Figure 30. Global Cell and Gene Therapy Bioassay Services Market Share Forecast by Application (2025-2030)
Figure 31. North America Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 41. France Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Region (2019-2030)
Figure 48. China Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 51. India Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
Figure 65. Cell and Gene Therapy Bioassay Services Market Drivers
Figure 66. Cell and Gene Therapy Bioassay Services Market Restraints
Figure 67. Cell and Gene Therapy Bioassay Services Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Cell and Gene Therapy Bioassay Services in 2023
Figure 70. Manufacturing Process Analysis of Cell and Gene Therapy Bioassay Services
Figure 71. Cell and Gene Therapy Bioassay Services Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Anabiotec
Ccrm
Nexelis
Pacific Biolabs
Ppd Laboratories
Intertek Pharmaceutical Services
Lonza
Porton Biopharma Ltd
Wuxi Advanced Therapies
Avomeen
Charles River Laboratories
Absorption Systems
Bioagilytix Labs
Catalent Inc
Svar Life Science Ab
jiaGou

Add To Cart

gouMai

Buy Now